Matches in Wikidata for { <http://www.wikidata.org/entity/Q92274018> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q92274018 description "clinical trial" @default.
- Q92274018 description "ensayo clínico" @default.
- Q92274018 description "ensayu clínicu" @default.
- Q92274018 description "klinisch onderzoek" @default.
- Q92274018 description "клінічне випробування" @default.
- Q92274018 description "临床试验" @default.
- Q92274018 name "Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 name "Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 type Item @default.
- Q92274018 label "Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 label "Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 prefLabel "Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 prefLabel "Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 P1050 Q92274018-36482CC4-EB42-48A0-A59A-1E6CAF356E92 @default.
- Q92274018 P1132 Q92274018-8AFE2D64-1CBE-4C3C-B451-F7CC0D2462F3 @default.
- Q92274018 P1476 Q92274018-11049C4A-F764-4492-B671-29266305E30C @default.
- Q92274018 P17 Q92274018-0967A699-60AA-4F21-AA3E-0DD15DCE27AE @default.
- Q92274018 P2899 Q92274018-FA7B684A-0426-4375-B52C-49C9A54208FC @default.
- Q92274018 P3098 Q92274018-59B2E332-701D-49FA-A838-B4291EDEE72C @default.
- Q92274018 P31 Q92274018-99334051-8D6D-4F11-9C99-DDCC68736C78 @default.
- Q92274018 P4844 Q92274018-4E8BFC98-3A96-4DB9-B7F8-9A2F34B289CA @default.
- Q92274018 P580 Q92274018-43030268-05C0-43E6-BA0B-0DFD02AA3B68 @default.
- Q92274018 P582 Q92274018-E36A4CBF-56D7-4AF7-853E-7090F1F73BA3 @default.
- Q92274018 P6099 Q92274018-A36F37D3-68D0-494F-B885-D8E00030BE4F @default.
- Q92274018 P8005 Q92274018-31DF6536-3931-46C6-9F2E-853F9D21A577 @default.
- Q92274018 P8363 Q92274018-96E595A9-72E7-436A-8D57-6287FCD2EFAE @default.
- Q92274018 P1050 Q356033 @default.
- Q92274018 P1132 "+60" @default.
- Q92274018 P1476 "Phase 1a/1b Open Label Dose-escalation and Expansion Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors" @default.
- Q92274018 P17 Q30 @default.
- Q92274018 P2899 "+18" @default.
- Q92274018 P3098 "NCT04344795" @default.
- Q92274018 P31 Q30612 @default.
- Q92274018 P4844 Q13896859 @default.
- Q92274018 P580 "2020-04-22T00:00:00Z" @default.
- Q92274018 P582 "2021-08-31T00:00:00Z" @default.
- Q92274018 P6099 Q5452194 @default.
- Q92274018 P8005 Q76649708 @default.
- Q92274018 P8363 Q78089383 @default.